自主回収｜クラス１｜報道発表資料｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_07124.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. Pro saves automatically start preparing the external RFC 3161 timestamp, and only unfinished records need one more preparation step before download.
自主回収｜クラス１｜報道発表資料｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the voluntary recall of pharmaceuticals by Takeda Teva Pharma Co., Ltd. The company has initiated recalls of Ranitidine Tablets 75mg and 150mg "Taiyo" and Ranitidine Injections 50mg and 100mg "Taiyo". This is classified as Class I, the most serious recall category. The notice was issued on October 3, 2019, by Japan's Ministry of Health, Labour and Welfare. Contact information for the Surveillance and Control Division and the Pharmaceutical Safety Division is provided. Further details are available in Takeda Teva Pharma's press release.
